351 related articles for article (PubMed ID: 15964656)
1. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.
Liu CJ; Chen PJ; Jeng YM; Huang WL; Yang WS; Lai MY; Kao JH; Chen DS
J Hepatol; 2005 Aug; 43(2):235-42. PubMed ID: 15964656
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
4. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
[TBL] [Abstract][Full Text] [Related]
5. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C.
Hsu CS; Liu CJ; Liu CH; Wang CC; Chen CL; Lai MY; Chen PJ; Kao JH; Chen DS
Liver Int; 2008 Feb; 28(2):271-7. PubMed ID: 18028320
[TBL] [Abstract][Full Text] [Related]
6. Association of serum adipocytokines with insulin resistance and liver injury in patients with chronic hepatitis C genotype 4.
Khattab MA; Eslam M; Aly MM; Shatat M; Hussen A; Moussa YI; Elsaghir G; Abdalhalim H; Aly A; Gaber S; Harrison SA
J Clin Gastroenterol; 2012; 46(10):871-9. PubMed ID: 22664476
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin changes in HCV-Genotype 4: relation to liver histology and response to treatment.
Derbala M; Rizk N; Al-Kaabi S; Amer A; Shebl F; Al Marri A; Aigha I; Alyaesi D; Mohamed H; Aman H; Basem N
J Viral Hepat; 2009 Oct; 16(10):689-96. PubMed ID: 19486470
[TBL] [Abstract][Full Text] [Related]
8. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
[TBL] [Abstract][Full Text] [Related]
9. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
[TBL] [Abstract][Full Text] [Related]
10. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4.
Ashour E; Samy N; Sayed M; Imam A
Clin Lab; 2010; 56(3-4):103-10. PubMed ID: 20476641
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
[TBL] [Abstract][Full Text] [Related]
12. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE
Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516
[TBL] [Abstract][Full Text] [Related]
13. Serum adiponectin in chronic hepatitis C and B.
Siagris D; Vafiadis G; Michalaki M; Lekkou A; Starakis I; Makri M; Margaritis V; Christofidou M; Tsamandas AC; Labropoulou-Karatza C
J Viral Hepat; 2007 Aug; 14(8):577-83. PubMed ID: 17650292
[TBL] [Abstract][Full Text] [Related]
14. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
Liu CJ; Jeng YM; Chen PJ; Lai MY; Yang HC; Huang WL; Kao JH; Chen DS
Antivir Ther; 2005; 10(3):405-15. PubMed ID: 15918331
[TBL] [Abstract][Full Text] [Related]
15. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
[TBL] [Abstract][Full Text] [Related]
16. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
[TBL] [Abstract][Full Text] [Related]
17. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
18. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
[TBL] [Abstract][Full Text] [Related]
19. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
[TBL] [Abstract][Full Text] [Related]
20. Serum lipid pattern in chronic hepatitis C: histological and virological correlations.
Siagris D; Christofidou M; Theocharis GJ; Pagoni N; Papadimitriou C; Lekkou A; Thomopoulos K; Starakis I; Tsamandas AC; Labropoulou-Karatza C
J Viral Hepat; 2006 Jan; 13(1):56-61. PubMed ID: 16364083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
